Bilcare Limited Revenue Falls 6.92% to ₹7,335 Million in FY26

Bilcare Limited reported FY26 revenue of ₹7,335.37 million, down 6.92% from ₹7,880.36 million in FY25, while net income improved to ₹17.28 million from a ₹7.84 million loss in the preceding year. The figures show lower annual sales alongside a return to reported profitability.

What did Bilcare's FY26 financial performance show?

Bilcare recorded total revenue of ₹7,335.37 million for the year ended 31 March 2026, compared with ₹7,880.36 million in FY25. The 6.92% year-on-year decline followed a 5.47% revenue increase reported in FY25, indicating that the company did not sustain the prior year's sales recovery.

Gross profit was ₹2,400.37 million in FY26, lower than ₹2,488.77 million in FY25. Despite the decline in absolute gross profit, the gross profit margin rose to 32.72% from 31.58%, reflecting a higher gross profit share of revenue. Annual operating income was ₹248.77 million, according to the reported income-statement data.

The company reported net income of ₹17.28 million for FY26, compared with a net loss of ₹7.84 million for FY25. This followed a substantially larger loss of ₹332.42 million in FY24. The reported profit is therefore a change in direction from the losses disclosed for the preceding two financial years, although it remains small relative to Bilcare's revenue base.

How did Bilcare perform in the latest reported quarter?

Bilcare reported revenue of ₹2,258.60 million in its latest quarterly earnings report, up 20.36% from ₹1,876.57 million in the preceding quarter. The latest reported quarter was released on 13 August 2026 and is identified as Q1 FY2026-27 in the supplied earnings information.

Quarterly net income was ₹127.00 million, compared with ₹238.48 million in the prior quarter. The reported quarterly EPS was ₹5.39, while the company’s stated trailing 12-month EPS was ₹4.78. The figures show that sales increased quarter on quarter, but reported net income was lower than in the preceding quarter.

Latest-quarter gross profit stood at ₹866.60 million. Quarterly operating income was ₹329.10 million and EBITDA was ₹378.48 million. The supplied data also states that gross profit increased 28.54% from the previous quarter and EBITDA changed by 1.26% quarter on quarter.

Why is the 3 November board meeting important for Bilcare?

Bilcare's board was scheduled to meet on 3 November 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The meeting was disclosed through a Bombay Stock Exchange intimation dated 27 October 2026.

The Q2 FY2026-27 results are relevant because they will provide the next official update after the June-quarter release. They are expected to show whether the higher quarterly revenue reported in the latest available earnings data continued into the September quarter. No Q2 revenue, profit, margin or forecast figure was included in the supplied material.

The board's stated agenda is limited to consideration and approval of unaudited financial results. Investors will therefore need to rely on the released standalone and consolidated statements for confirmed information on the company’s sales, profitability and operations for the first half of FY2026-27.

How has Bilcare's revenue trend changed over recent years?

Bilcare's annual revenue has moved unevenly over the five reported financial years through FY26. Revenue increased from ₹8,447.03 million in FY22 to ₹9,816.22 million in FY23, then declined to ₹7,471.79 million in FY24 before recovering to ₹7,880.36 million in FY25 and falling again in FY26.

The FY26 revenue figure is about 25.3% below the ₹9,816.22 million reported in FY23. Gross profit has been comparatively more stable, ranging from ₹2,384.75 million to ₹2,488.77 million between FY23 and FY26. As revenue declined in FY26, the gross margin rose to the highest level among the five reported annual periods.

What do these results mean for investors and operations?

The FY26 data presents two different trends for investors to assess. Revenue and gross profit declined year on year, but gross margin improved and Bilcare returned to a reported annual net profit. The latest quarterly data also showed a sequential increase in revenue, although net income was below the preceding quarter's figure.

Bilcare's FY26 sales were split between India and markets outside India, based on the reported revenue breakdown. India accounted for ₹4,744.8 million, or 64.7% of total sales, while outside-India revenue was ₹2,590.6 million, or 35.3%. This mix means the company's reported sales base includes both domestic and overseas operations.

The September-quarter results will be the next disclosed financial reference point. Until those results are released, the available evidence is limited to the annual FY26 figures, the June-quarter data and the announced board meeting agenda.

Conclusion

Bilcare's FY26 results show a 6.92% decline in annual revenue to ₹7,335.37 million, alongside improved gross margin and a return to a modest net profit of ₹17.28 million. The June-quarter figures added a 20.36% sequential revenue increase, but quarterly net income declined from the preceding quarter.

The immediate item to watch is the board's consideration of unaudited Q2 FY2026-27 standalone and consolidated results for the period ended 30 September 2026. Those disclosures will provide the next confirmed view of Bilcare's revenue, margins and profitability after the June-quarter update.